Exploring the influence of behavioral factors on depression and anxiety scores during the COVID-19 pandemic: insights from the Virginia statewide COVIDsmart longitudinal study.

Publication date: Sep 08, 2023

Amidst the COVID-19 pandemic, there has been growing concern about the declining mental health and healthy behaviors compared to pre-pandemic levels. Despite this, there is a lack of longitudinal studies that have examined the relationship between health behaviors and mental health during the pandemic. In response, the statewide COVIDsmart longitudinal study was launched. The study’s main objective is to better understand the effects of the pandemic on mental health. Findings may provide a foundation for the identification of public health strategies to mitigate future negative impacts of the pandemic. Following online recruitment in spring of 2021, adults, ages 18 to 87, filled out social, mental, economic, occupational, and physical health questionnaires on the digital COVIDsmart platform at baseline and through six monthly follow-ups. Changes in the participant’s four health behaviors (e. g., tobacco and alcohol consumption, physical activity, and social media use), along with sex, age, loneliness score, and reported social and economic (SE) hardships, were analyzed for within-between group associations with depression and anxiety scores using Mixed Models Repeated Measures. In this study, of the 669 individuals who reported, the within-between group analysis indicated that younger adults (Fā€‰=ā€‰23. 81, pā€‰

Open Access PDF

Concepts Keywords
Alcohol Alcohol
Pandemic COVID-19
Therapy Health behaviors
Virginia Health promotion
Mental health
Physical activity
Social media


Type Source Name
disease MESH COVID-19 pandemic
disease VO LACK
drug DRUGBANK Tropicamide
disease VO monthly
drug DRUGBANK Ethanol
disease MESH loneliness
pathway REACTOME Reproduction
drug DRUGBANK Coenzyme M
disease VO population
disease MESH psychological distress
disease MESH infection
drug DRUGBANK Trestolone
disease MESH Anxiety Disorder
disease VO time
disease MESH educational attainment
disease VO effective
disease VO frequency
disease MESH mental disorders
drug DRUGBANK Methylergometrine
disease MESH morbidity
disease MESH low socioeconomic status
disease VO protocol
disease VO USA
drug DRUGBANK Factor IX Complex (Human)
disease MESH lifestyle
disease VO Pal
drug DRUGBANK Indoleacetic acid
disease MESH causality
drug DRUGBANK Gold
drug DRUGBANK Isosorbide Mononitrate

Original Article

(Visited 1 times, 1 visits today)